Rizatriptan Benzoate

Product NDC: 45865-825
11-digit product format: 458650825
Labeler code: 45865
Product ID: 45865-825_9ab487ec-5da3-cc72-e053-2a95a90a4e37
Type: HUMAN PRESCRIPTION DRUG
Nonproprietary name: Rizatriptan Benzoate
Dosage form: TABLET
Route: ORAL
Labeler: Medsource Pharmaceuticals
Application: ANDA200482
Marketing category: ANDA
Marketing start: 2012-12-31
Marketing end: 0000-00-00
Substance: RIZATRIPTAN BENZOATE
Active strength: 10 mg/1
Pharmacologic classes: Serotonin 1b Receptor Agonists [MoA],Serotonin 1d Receptor Agonists [MoA],Serotonin-1b and Serotonin-1d Receptor Agonist [EPC]
NDC exclude flag: No
Listing certified through: 2020-12-31
Current FDA listing: Historical FDA.report record

NDC auxiliary status#

These records are reproduced from FDA’s unfinished, excluded, and compounder listings. They describe what appeared in the source files; a missing record does not establish a regulatory status. View all current auxiliary records, including entries without an NDC. · View the auxiliary file history.

Current NDC status page 1 of 1 · 2 matching rows.

Dataset, Scope, Product NDC table
Dataset	Scope	Product NDC	Package NDC	Code	Status	Reporting period	Source date
excluded product	product	45865-825		I	Inactivated by FDA		2026-08-17
excluded package	package	45865-825	45865-825-12	I	Inactivated by FDA		2026-08-17

Observed NDC auxiliary status history#

This history shows the information present in each captured FDA auxiliary file. It is not a continuous regulatory timeline, and a missing record does not establish a status.

Historic NDC status page 1 of 1 · 32 matching rows.

View current auxiliary records. · View the auxiliary file history.

Captured / source date, Dataset, Scope table
Captured / source date	Dataset	Scope	Package NDC	Code	Status	Snapshot	Source SHA-256
2025-12-14 17:58 UTC · source 2025-12-05	excluded product	product		I	Inactivated by FDA	`d630ba8d3edf…`	`732f749b63fb…`
2025-12-14 17:58 UTC · source 2025-12-05	excluded package	package	45865-825-12	I	Inactivated by FDA	`d630ba8d3edf…`	`732f749b63fb…`
2025-08-27 00:01 UTC · source 2025-08-26	excluded product	product		I	Inactivated by FDA	`f5e01cc5f278…`	`a2eaf40c39c3…`
2025-08-27 00:01 UTC · source 2025-08-26	excluded package	package	45865-825-12	I	Inactivated by FDA	`f5e01cc5f278…`	`a2eaf40c39c3…`
2025-04-01 02:39 UTC · source 2025-03-31	excluded product	product		I	Inactivated by FDA	`2ef7874e63bc…`	`57b86245f4fa…`
2025-04-01 02:39 UTC · source 2025-03-31	excluded package	package	45865-825-12	I	Inactivated by FDA	`2ef7874e63bc…`	`57b86245f4fa…`
2025-03-28 20:22 UTC · source 2025-03-28	excluded product	product		I	Inactivated by FDA	`a1b67e2a42f9…`	`c4cf2c586c0d…`
2025-03-28 20:22 UTC · source 2025-03-28	excluded package	package	45865-825-12	I	Inactivated by FDA	`a1b67e2a42f9…`	`c4cf2c586c0d…`
2025-03-22 03:12 UTC · source 2025-03-21	excluded product	product		I	Inactivated by FDA	`cfe11265f3b6…`	`090c488252e2…`
2025-03-22 03:12 UTC · source 2025-03-21	excluded package	package	45865-825-12	I	Inactivated by FDA	`cfe11265f3b6…`	`090c488252e2…`
2025-03-10 12:48 UTC · source 2025-03-10	excluded product	product		I	Inactivated by FDA	`cdf11ea48f46…`	`ba0047e9e063…`
2025-03-10 12:48 UTC · source 2025-03-10	excluded package	package	45865-825-12	I	Inactivated by FDA	`cdf11ea48f46…`	`ba0047e9e063…`
2025-02-02 03:52 UTC · source 2025-01-31	excluded product	product		I	Inactivated by FDA	`302b2466d912…`	`e7b80fea0513…`
2025-02-02 03:52 UTC · source 2025-01-31	excluded package	package	45865-825-12	I	Inactivated by FDA	`302b2466d912…`	`e7b80fea0513…`
2025-01-20 13:05 UTC · source 2025-01-20	excluded product	product		I	Inactivated by FDA	`ed331223b511…`	`672a5bd82f5f…`
2025-01-20 13:05 UTC · source 2025-01-20	excluded package	package	45865-825-12	I	Inactivated by FDA	`ed331223b511…`	`672a5bd82f5f…`
2025-01-11 03:41 UTC · source 2025-01-10	excluded product	product		I	Inactivated by FDA	`0efc9e666f02…`	`f202fb6c5f17…`
2025-01-11 03:41 UTC · source 2025-01-10	excluded package	package	45865-825-12	I	Inactivated by FDA	`0efc9e666f02…`	`f202fb6c5f17…`
2024-11-09 02:27 UTC · source 2024-11-08	excluded product	product		I	Inactivated by FDA	`ad56d346431e…`	`cc804d4bbf1e…`
2024-11-09 02:27 UTC · source 2024-11-08	excluded package	package	45865-825-12	I	Inactivated by FDA	`ad56d346431e…`	`cc804d4bbf1e…`
2024-10-04 04:10 UTC · source 2024-10-03	excluded product	product		I	Inactivated by FDA	`367a005e9d99…`	`383a685ebd0f…`
2024-10-04 04:10 UTC · source 2024-10-03	excluded package	package	45865-825-12	I	Inactivated by FDA	`367a005e9d99…`	`383a685ebd0f…`
2024-07-10 04:00 UTC · source 2024-07-09	excluded product	product		I	Inactivated by FDA	`557ba5c1ecfa…`	`9c80585c8c6e…`
2024-07-10 04:00 UTC · source 2024-07-09	excluded package	package	45865-825-12	I	Inactivated by FDA	`557ba5c1ecfa…`	`9c80585c8c6e…`
2024-05-28 21:12 UTC · source 2024-05-28	excluded product	product		I	Inactivated by FDA	`8af77b9d5b6f…`	`d9bbb34c5368…`
2024-05-28 21:12 UTC · source 2024-05-28	excluded package	package	45865-825-12	I	Inactivated by FDA	`8af77b9d5b6f…`	`d9bbb34c5368…`
2024-05-15 03:39 UTC · source 2024-05-14	excluded product	product		I	Inactivated by FDA	`834df4deac94…`	`adcc014656a3…`
2024-05-15 03:39 UTC · source 2024-05-14	excluded package	package	45865-825-12	I	Inactivated by FDA	`834df4deac94…`	`adcc014656a3…`
2024-03-11 06:39 UTC · source 2024-03-08	excluded product	product		I	Inactivated by FDA	`1332a3947898…`	`d4bfe170f9cd…`
2024-03-11 06:39 UTC · source 2024-03-08	excluded package	package	45865-825-12	I	Inactivated by FDA	`1332a3947898…`	`d4bfe170f9cd…`
2022-08-30 03:57 UTC · source 2022-08-29	excluded product	product		E	Excluded after deficient or non-compliant submission was not corrected	`fb8cb913e6d1…`	`eb8c232b6be0…`
2022-08-30 03:57 UTC · source 2022-08-29	excluded package	package	45865-825-12	E	Excluded after deficient or non-compliant submission was not corrected	`fb8cb913e6d1…`	`eb8c232b6be0…`

Source provenance: Browse the complete Orange Book source catalog · source snapshot 42.

Orange Book products#

Current product rows page 1 of 1 · 2 matching rows.

Application-product, Trade name, Ingredient table
Application-product	Trade name	Ingredient	Strength	Dosage form / route	TE codes	RLD / RS	Approval date
A200482-001	RIZATRIPTAN BENZOATE	RIZATRIPTAN BENZOATE	EQ 5MG BASE	TABLET / ORAL			2012-12-31
A200482-002	RIZATRIPTAN BENZOATE	RIZATRIPTAN BENZOATE	EQ 10MG BASE	TABLET / ORAL			2012-12-31

Observed Orange Book product history#

Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.

Product history page 1 of 3 · 84 observed states.

Captured, Edition, Application-product table
Captured	Edition	Application-product	Trade name	Strength	Dosage form / route	Product TE source text	Approval date	Source SHA-256
2026-08-18 06:07:40	2026-07	A200482-001	RIZATRIPTAN BENZOATE	EQ 5MG BASE	TABLET / ORAL		2012-12-31	`caaa826d4ba7…`
2026-08-18 06:07:40	2026-07	A200482-002	RIZATRIPTAN BENZOATE	EQ 10MG BASE	TABLET / ORAL		2012-12-31	`caaa826d4ba7…`
2026-02-19 14:30 UTC	2026-02	A200482-001	RIZATRIPTAN BENZOATE	EQ 5MG BASE	TABLET / ORAL		2012-12-31	`011fe1cb6892…`
2026-02-19 14:30 UTC	2026-02	A200482-002	RIZATRIPTAN BENZOATE	EQ 10MG BASE	TABLET / ORAL		2012-12-31	`011fe1cb6892…`
2025-12-14 10:44 UTC · 2 captures of this ZIP	2025-12	A200482-001	RIZATRIPTAN BENZOATE	EQ 5MG BASE	TABLET / ORAL		2012-12-31	`31067a03dcf5…`
2025-12-14 10:44 UTC · 2 captures of this ZIP	2025-12	A200482-002	RIZATRIPTAN BENZOATE	EQ 10MG BASE	TABLET / ORAL		2012-12-31	`31067a03dcf5…`
2025-08-23 18:47 UTC	2025-08	A200482-001	RIZATRIPTAN BENZOATE	EQ 5MG BASE	TABLET / ORAL		2012-12-31	`6a471c1ec25d…`
2025-08-23 18:47 UTC	2025-08	A200482-002	RIZATRIPTAN BENZOATE	EQ 10MG BASE	TABLET / ORAL		2012-12-31	`6a471c1ec25d…`
2025-03-22 03:13 UTC · 3 captures of this ZIP	2025-03	A200482-001	RIZATRIPTAN BENZOATE	EQ 5MG BASE	TABLET / ORAL		2012-12-31	`fd3edfee7708…`
2025-03-22 03:13 UTC · 3 captures of this ZIP	2025-03	A200482-002	RIZATRIPTAN BENZOATE	EQ 10MG BASE	TABLET / ORAL		2012-12-31	`fd3edfee7708…`
2025-02-26 10:13 UTC · 3 captures of this ZIP	2025-02	A200482-001	RIZATRIPTAN BENZOATE	EQ 5MG BASE	TABLET / ORAL		2012-12-31	`b8a1b40f171c…`
2025-02-26 10:13 UTC · 3 captures of this ZIP	2025-02	A200482-002	RIZATRIPTAN BENZOATE	EQ 10MG BASE	TABLET / ORAL		2012-12-31	`b8a1b40f171c…`
2025-01-19 17:59 UTC · 7 captures of this ZIP	2025-01	A200482-001	RIZATRIPTAN BENZOATE	EQ 5MG BASE	TABLET / ORAL		2012-12-31	`03ed91905a0d…`
2025-01-19 17:59 UTC · 7 captures of this ZIP	2025-01	A200482-002	RIZATRIPTAN BENZOATE	EQ 10MG BASE	TABLET / ORAL		2012-12-31	`03ed91905a0d…`
2024-12-13 21:23 UTC · 2 captures of this ZIP	2024-12	A200482-001	RIZATRIPTAN BENZOATE	EQ 5MG BASE	TABLET / ORAL		2012-12-31	`2680178bc6a6…`
2024-12-13 21:23 UTC · 2 captures of this ZIP	2024-12	A200482-002	RIZATRIPTAN BENZOATE	EQ 10MG BASE	TABLET / ORAL		2012-12-31	`2680178bc6a6…`
2024-09-14 05:58 UTC · 2 captures of this ZIP	2024-09	A200482-001	RIZATRIPTAN BENZOATE	EQ 5MG BASE	TABLET / ORAL		2012-12-31	`5bbf6a4d5a75…`
2024-09-14 05:58 UTC · 2 captures of this ZIP	2024-09	A200482-002	RIZATRIPTAN BENZOATE	EQ 10MG BASE	TABLET / ORAL		2012-12-31	`5bbf6a4d5a75…`
2024-11-08 22:44 UTC · 3 captures of this ZIP	2024-11	A200482-001	RIZATRIPTAN BENZOATE	EQ 5MG BASE	TABLET / ORAL		2012-12-31	`d8e5a09893c0…`
2024-11-08 22:44 UTC · 3 captures of this ZIP	2024-11	A200482-002	RIZATRIPTAN BENZOATE	EQ 10MG BASE	TABLET / ORAL		2012-12-31	`d8e5a09893c0…`
2024-10-29 15:01 UTC	2024-10	A200482-001	RIZATRIPTAN BENZOATE	EQ 5MG BASE	TABLET / ORAL		2012-12-31	`d06236e962d9…`
2024-10-29 15:01 UTC	2024-10	A200482-002	RIZATRIPTAN BENZOATE	EQ 10MG BASE	TABLET / ORAL		2012-12-31	`d06236e962d9…`
2024-08-13 05:28 UTC · 3 captures of this ZIP	2024-08	A200482-001	RIZATRIPTAN BENZOATE	EQ 5MG BASE	TABLET / ORAL	AB	2012-12-31	`79d66fd596c7…`
2024-08-13 05:28 UTC · 3 captures of this ZIP	2024-08	A200482-002	RIZATRIPTAN BENZOATE	EQ 10MG BASE	TABLET / ORAL	AB	2012-12-31	`79d66fd596c7…`
2024-07-13 05:37 UTC · 2 captures of this ZIP	2024-07	A200482-001	RIZATRIPTAN BENZOATE	EQ 5MG BASE	TABLET / ORAL	AB	2012-12-31	`301d65b070ca…`
2024-07-13 05:37 UTC · 2 captures of this ZIP	2024-07	A200482-002	RIZATRIPTAN BENZOATE	EQ 10MG BASE	TABLET / ORAL	AB	2012-12-31	`301d65b070ca…`
2024-06-18 03:08 UTC · 5 captures of this ZIP	2024-06	A200482-001	RIZATRIPTAN BENZOATE	EQ 5MG BASE	TABLET / ORAL	AB	2012-12-31	`1e350fbaab3a…`
2024-06-18 03:08 UTC · 5 captures of this ZIP	2024-06	A200482-002	RIZATRIPTAN BENZOATE	EQ 10MG BASE	TABLET / ORAL	AB	2012-12-31	`1e350fbaab3a…`
2024-05-31 18:47 UTC	2024-05	A200482-001	RIZATRIPTAN BENZOATE	EQ 5MG BASE	TABLET / ORAL	AB	2012-12-31	`8072bd15b7f6…`
2024-05-31 18:47 UTC	2024-05	A200482-002	RIZATRIPTAN BENZOATE	EQ 10MG BASE	TABLET / ORAL	AB	2012-12-31	`8072bd15b7f6…`
2022-06-29 02:47 UTC · 2 captures of this ZIP	2022-06	A200482-001	RIZATRIPTAN BENZOATE	EQ 5MG BASE	TABLET / ORAL	AB	2012-12-31	`5c6f7cd8ea54…`
2022-06-29 02:47 UTC · 2 captures of this ZIP	2022-06	A200482-002	RIZATRIPTAN BENZOATE	EQ 10MG BASE	TABLET / ORAL	AB	2012-12-31	`5c6f7cd8ea54…`
2022-04-08 23:34 UTC	2022-04	A200482-001	RIZATRIPTAN BENZOATE	EQ 5MG BASE	TABLET / ORAL	AB	2012-12-31	`5d02ea3f76ae…`
2022-04-08 23:34 UTC	2022-04	A200482-002	RIZATRIPTAN BENZOATE	EQ 10MG BASE	TABLET / ORAL	AB	2012-12-31	`5d02ea3f76ae…`
2022-04-04 05:41 UTC	2022-04	A200482-001	RIZATRIPTAN BENZOATE	EQ 5MG BASE	TABLET / ORAL	AB	2012-12-31	`4b0b4de00fa7…`
2022-04-04 05:41 UTC	2022-04	A200482-002	RIZATRIPTAN BENZOATE	EQ 10MG BASE	TABLET / ORAL	AB	2012-12-31	`4b0b4de00fa7…`
2019-12-13 00:20 UTC	2019-12	A200482-001	RIZATRIPTAN BENZOATE	EQ 5MG BASE	TABLET / ORAL	AB	2012-12-31	`74a2ff9319b5…`
2019-12-13 00:20 UTC	2019-12	A200482-002	RIZATRIPTAN BENZOATE	EQ 10MG BASE	TABLET / ORAL	AB	2012-12-31	`74a2ff9319b5…`
2022-03-09 01:35 UTC	2022-03	A200482-001	RIZATRIPTAN BENZOATE	EQ 5MG BASE	TABLET / ORAL	AB	2012-12-31	`bb7c543d1eb4…`
2022-03-09 01:35 UTC	2022-03	A200482-002	RIZATRIPTAN BENZOATE	EQ 10MG BASE	TABLET / ORAL	AB	2012-12-31	`bb7c543d1eb4…`

Observed Orange Book normalized TE history#

Normalized TE history page 1 of 2 · 60 observed states.

Captured, Edition, Application-product table
Captured	Edition	Application-product	TE code	Order	Source SHA-256
2024-08-13 05:28 UTC · 3 captures of this ZIP	2024-08	A200482-001	AB	1	`79d66fd596c7…`
2024-08-13 05:28 UTC · 3 captures of this ZIP	2024-08	A200482-002	AB	1	`79d66fd596c7…`
2024-07-13 05:37 UTC · 2 captures of this ZIP	2024-07	A200482-001	AB	1	`301d65b070ca…`
2024-07-13 05:37 UTC · 2 captures of this ZIP	2024-07	A200482-002	AB	1	`301d65b070ca…`
2024-06-18 03:08 UTC · 5 captures of this ZIP	2024-06	A200482-001	AB	1	`1e350fbaab3a…`
2024-06-18 03:08 UTC · 5 captures of this ZIP	2024-06	A200482-002	AB	1	`1e350fbaab3a…`
2024-05-31 18:47 UTC	2024-05	A200482-001	AB	1	`8072bd15b7f6…`
2024-05-31 18:47 UTC	2024-05	A200482-002	AB	1	`8072bd15b7f6…`
2022-06-29 02:47 UTC · 2 captures of this ZIP	2022-06	A200482-001	AB	1	`5c6f7cd8ea54…`
2022-06-29 02:47 UTC · 2 captures of this ZIP	2022-06	A200482-002	AB	1	`5c6f7cd8ea54…`
2022-04-08 23:34 UTC	2022-04	A200482-001	AB	1	`5d02ea3f76ae…`
2022-04-08 23:34 UTC	2022-04	A200482-002	AB	1	`5d02ea3f76ae…`
2022-04-04 05:41 UTC	2022-04	A200482-001	AB	1	`4b0b4de00fa7…`
2022-04-04 05:41 UTC	2022-04	A200482-002	AB	1	`4b0b4de00fa7…`
2019-12-13 00:20 UTC	2019-12	A200482-001	AB	1	`74a2ff9319b5…`
2019-12-13 00:20 UTC	2019-12	A200482-002	AB	1	`74a2ff9319b5…`
2022-03-09 01:35 UTC	2022-03	A200482-001	AB	1	`bb7c543d1eb4…`
2022-03-09 01:35 UTC	2022-03	A200482-002	AB	1	`bb7c543d1eb4…`
2021-12-28 21:50 UTC	2021-12	A200482-001	AB	1	`782e0a99824c…`
2021-12-28 21:50 UTC	2021-12	A200482-002	AB	1	`782e0a99824c…`
2021-05-05 16:15 UTC · 3 captures of this ZIP	2021-05	A200482-001	AB	1	`87673890dc5c…`
2021-05-05 16:15 UTC · 3 captures of this ZIP	2021-05	A200482-002	AB	1	`87673890dc5c…`
2021-03-12 10:30 UTC	2021-03	A200482-001	AB	1	`5aa47cf7b7d7…`
2021-03-12 10:30 UTC	2021-03	A200482-002	AB	1	`5aa47cf7b7d7…`
2020-12-22 03:56 UTC	2020-12	A200482-001	AB	1	`8869cabd3fbd…`
2020-12-22 03:56 UTC	2020-12	A200482-002	AB	1	`8869cabd3fbd…`
2020-11-12 02:37 UTC	2020-11	A200482-001	AB	1	`c0c555d07b60…`
2020-11-12 02:37 UTC	2020-11	A200482-002	AB	1	`c0c555d07b60…`
2019-12-14 00:12 UTC	2019-12	A200482-001	AB	1	`3f01610625f2…`
2019-12-14 00:12 UTC	2019-12	A200482-002	AB	1	`3f01610625f2…`
2019-09-15 20:21 UTC	2019-09	A200482-001	AB	1	`b00525d2431f…`
2019-09-15 20:21 UTC	2019-09	A200482-002	AB	1	`b00525d2431f…`
2019-07-19 19:46 UTC	2019-07	A200482-001	AB	1	`ea99ee380514…`
2019-07-19 19:46 UTC	2019-07	A200482-002	AB	1	`ea99ee380514…`
2024-03-16 18:09 UTC · 4 captures of this ZIP	2024-03	A200482-001	AB	1	`6a51e52b5d6a…`
2024-03-16 18:09 UTC · 4 captures of this ZIP	2024-03	A200482-002	AB	1	`6a51e52b5d6a…`
2024-02-18 07:12 UTC	2024-02	A200482-001	AB	1	`1c564ffb4f44…`
2024-02-18 07:12 UTC	2024-02	A200482-002	AB	1	`1c564ffb4f44…`
2023-12-20 04:57 UTC	2023-12	A200482-001	AB	1	`ea1830bbd6c7…`
2023-12-20 04:57 UTC	2023-12	A200482-002	AB	1	`ea1830bbd6c7…`

DailyMed Product Concepts#

Product concept, Relation, Version table
Product concept	Relation	Version	Effective
f2791553-0b76-42f4-8d49-af3eda072bfb	Product name	1	20251117
707ffe6e-db52-42b0-9a65-a0c00213f04f	Product name	1	20231006
8b537454-32b8-7e64-1395-258682782d07	Product name	5	20170424

FDA-Initiated Inactive NDC Indexing#

NDC, Effective, Action table
NDC	Effective	Action	Document	Indexing SPL	Related label
45865-825-12	2023-01-30	C162847	48780-1	f386c649-a9ae-0266-e053-dadaa90a7c1a	These highlights do not include all the information needed to use rizatriptan benzoate tablets safely and effectively. See full prescribing information for rizatriptan benzoate tablets. Rizatriptan benzoate tablets, for oral use Initial U.S. Approval:1998

DailyMed Package Descriptions#

Package NDC, Product, Description table
Package NDC	Product	Description	Form	Quantity	Strength	SPL version
45865-825-12	Rizatriptan Benzoate	6 in 1 BLISTER PACK	TABLET	6		2
45865-825-12	Rizatriptan Benzoate	2 in 1 CARTON	TABLET	2		2

DailyMed Socrata Ingredients#

Ingredient, Type, UNII table
Ingredient	Type	UNII	DailyMed label	SPL version
RIZATRIPTAN BENZOATE	ACTIVE INGREDIENT	WR978S7QHH	RIZATRIPTAN BENZOATE TABLET [MEDSOURCE PHARMACEUTICALS]	1
RIZATRIPTAN	ACTIVE MOIETY	51086HBW8G	RIZATRIPTAN BENZOATE TABLET [MEDSOURCE PHARMACEUTICALS]	1
CELLULOSE, MICROCRYSTALLINE	INACTIVE INGREDIENT	OP1R32D61U	RIZATRIPTAN BENZOATE TABLET [MEDSOURCE PHARMACEUTICALS]	1
FERRIC OXIDE RED	INACTIVE INGREDIENT	1K09F3G675	RIZATRIPTAN BENZOATE TABLET [MEDSOURCE PHARMACEUTICALS]	1
LACTOSE MONOHYDRATE	INACTIVE INGREDIENT	EWQ57Q8I5X	RIZATRIPTAN BENZOATE TABLET [MEDSOURCE PHARMACEUTICALS]	1
MAGNESIUM STEARATE	INACTIVE INGREDIENT	70097M6I30	RIZATRIPTAN BENZOATE TABLET [MEDSOURCE PHARMACEUTICALS]	1
STARCH, CORN	INACTIVE INGREDIENT	O8232NY3SJ	RIZATRIPTAN BENZOATE TABLET [MEDSOURCE PHARMACEUTICALS]	1

DailyMed Dashboard NDC Coverage#

NDC, Dashboard title, SPL version table
NDC	Dashboard title	SPL version	Validation	Dashboard ZIP
45865-825	RIZATRIPTAN BENZOATE TABLET [MEDSOURCE PHARMACEUTICALS]	2	Legacy NDC, 2 package rows	20191228_2086f746-f921-1af1-e054-00144ff88e88.zip

UNII, Preferred term, Registry number table
UNII	Preferred term	Registry number	Matched term
WR978S7QHH	RIZATRIPTAN BENZOATE	145202-66-0	RIZATRIPTAN BENZOATE

DailyMed RxNorm Mappings#

RxCUI, RxNorm string, TTY table
RxCUI	RxNorm string	TTY	DailyMed	SPL version
314209	rizatriptan benzoate 10 MG Oral Tablet	PSN	2086f746-f921-1af1-e054-00144ff88e88	2
314209	rizatriptan 10 MG Oral Tablet	SCD	2086f746-f921-1af1-e054-00144ff88e88	2
314209	rizatriptan 10 MG (as rizatriptan benzoate 14.53 MG) Oral Tablet	SY	2086f746-f921-1af1-e054-00144ff88e88	2

Packages#

Package NDC, 11-digit format, Description table
Package NDC	11-digit format	Description	Units	Marketing start	Marketing end	Sample	Exclude flag	Status
45865-825-12	45865082512	2 BLISTER PACK in 1 CARTON (45865-825-12) > 6 TABLET in 1 BLISTER PACK	2 blister pack	2015-09-24	0000-00-00	No	No	Current